Pre-existing low-frequency resistance mutations increase the risk of antiretroviral treatment failure in HIV-1 naïve patients.

Author: Yifan SU ¹ ; Rentian CAI ¹ ; Yinyin ZHU ² ; Mingli ZHONG ³ ; Mingxue QI ¹ ; Chen CHEN ¹ ; Zi YE ¹ ; Hongying ZHANG ³ ; Hongxia WEI ¹
Author Information

1. Department of Infectious Disease, The Second Hospital of Nanjing Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.
2. Nanjing Center for Disease Control and Prevention Affiliated with Nanjing Medical University, Nanjing, Jiangsu 211103, China.
3. Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
Publication Type:Letter
MeSH: Humans; HIV-1/genetics*; Anti-Retroviral Agents/therapeutic use*; Mutation/genetics*; Treatment Failure; HIV Infections/genetics*; Drug Resistance, Viral/genetics*; Anti-HIV Agents/therapeutic use*; Genotype
From: Chinese Medical Journal 2023;136(22):2756-2758
CountryChina
Language:English